Araz Marachelian Selected Research

Drug Therapy (Chemotherapy)

1/2023	Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
1/2020	The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
1/2016	The clinical management and outcomes of cervical neuroblastic tumors.
4/2015	131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
12/2013	Infectious complications in the first year following autologous hematopoietic progenitor cell rescue for children with brain tumors.
5/2012	The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
7/2010	Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
7/2009	High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Araz Marachelian Research Topics

Disease

35	Neuroblastoma 01/2024 - 08/2011
19	Neoplasms (Cancer) 01/2024 - 07/2009
3	Bacteremia 01/2016 - 12/2013
2	Fever (Fevers) 01/2024 - 04/2014
2	Residual Neoplasm 11/2023 - 05/2012
2	Thrombocytopenia (Thrombopenia) 01/2023 - 02/2015
2	Hypocalcemia 01/2016 - 08/2011
2	Hypokalemia 06/2015 - 08/2011
2	Neoplasm Metastasis (Metastasis) 08/2011 - 07/2009
2	Primitive Neuroectodermal Tumors (PNET) 01/2010 - 07/2009
1	Anorexia 01/2024
1	Pain (Aches) 01/2023
1	Acute Pain 01/2023
1	Hypercalcemia (Milk Alkali Syndrome) 01/2020
1	Hypertrophy 09/2018
1	Bone Diseases (Bone Disease) 10/2016
1	Diarrhea 04/2016
1	Hypotension (Low Blood Pressure) 01/2016
1	Hemorrhage 06/2015
1	Cardiotoxicity 02/2015
1	Ototoxicity 02/2015
1	Cholestasis 04/2014
1	Drug-Related Side Effects and Adverse Reactions 04/2014
1	Necrosis 04/2014
1	Disease Progression 04/2014
1	Brain Neoplasms (Brain Tumor) 12/2013
1	Communicable Diseases (Infectious Diseases) 12/2013
1	Infections 12/2013

Drug/Important Bio-Agent (IBA)

10	3-Iodobenzylguanidine (Iobenguane)IBA 01/2024 - 05/2012
5	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 05/2012
4	Monoclonal AntibodiesIBA 11/2023 - 02/2016
4	Vorinostat FDA Link 01/2023 - 06/2015
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 05/2012
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2017
3	RadiopharmaceuticalsIBA 03/2016 - 05/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2024 - 04/2016
2	Transaminases (Aminotransferases)IBA 01/2024 - 08/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2018
2	LigandsIBA 11/2023 - 02/2015
2	Etoposide (VP 16)FDA LinkGeneric 11/2023 - 07/2010
2	lorlatinibIBA 01/2023 - 01/2023
2	Radiation-Sensitizing AgentsIBA 01/2023 - 06/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 09/2017
2	RetinoidsIBA 01/2020 - 01/2018
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2020 - 01/2018
2	MLN 8237IBA 12/2018 - 04/2016
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 04/2016
2	dinutuximabIBA 05/2017 - 02/2016
2	FenretinideIBA 04/2014 - 11/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2024
1	Celecoxib (Celebrex)FDA Link 01/2024
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2024
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2024
1	ChemokinesIBA 11/2023
1	Chemotactic FactorsIBA 11/2023
1	CrizotinibIBA 01/2023
1	naxitamab-gqgkIBA 01/2023
1	flt3 ligand protein (flt3 ligand)IBA 01/2023
1	Circulating Tumor DNAIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Hypnotics and Sedatives (Sedatives)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Vitamin A (Retinol)FDA LinkGeneric 01/2020
1	TabletsIBA 12/2018
1	N-Myc Proto-Oncogene ProteinIBA 09/2018
1	DesminIBA 09/2018
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2016
1	Aurora Kinase AIBA 04/2016
1	Melphalan (Alkeran)FDA LinkGeneric 01/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Buthionine SulfoximineIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 02/2015
1	Dexrazoxane (Zinecard)FDA LinkGeneric 02/2015
1	AT 130IBA 02/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015
1	AnthracyclinesIBA 02/2015
1	Platinum Compounds (Compounds, Platinum)IBA 02/2015
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 04/2014
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2014
1	HemosiderinIBA 04/2014
1	EmulsionsIBA 04/2014
1	PowdersIBA 11/2013

Therapy/Procedure

25	Therapeutics 01/2024 - 07/2009
8	Drug Therapy (Chemotherapy) 01/2023 - 07/2009
3	Radiotherapy 01/2022 - 07/2009
2	Immunotherapy 01/2022 - 05/2017
1	Palliative Care (Palliative Therapy) 12/2023
1	Combination Drug Therapy (Combination Chemotherapy) 01/2023
1	Pain Management 01/2023
1	Terminal Care (Care, Terminal) 10/2020
1	Neoadjuvant Therapy 01/2020
1	Duration of Therapy 12/2019
1	Aftercare (After-Treatment) 10/2016
1	Stem Cell Transplantation 04/2015
1	Treatment Delay 02/2015
1	Catheters 12/2013
1	Cranial Irradiation 12/2013